Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.

about

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.

Item

http://www.wikidata.org/entity/Q55165596

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@en

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@nl

type

Item

label

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@en

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@nl

prefLabel

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@en

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@nl

P1476

Preclinical Development of a L ...... ere Combined Immunodeficiency.

@en

P2093

Alban Vignaud

http://www.w3.org/2001/XMLSchema#string

Axel Schambach

http://www.w3.org/2001/XMLSchema#string

Bernard Gjata

http://www.w3.org/2001/XMLSchema#string

Fang Zhang

http://www.w3.org/2001/XMLSchema#string

H Bobby Gaspar

http://www.w3.org/2001/XMLSchema#string

Michael Rothe

http://www.w3.org/2001/XMLSchema#string

Sabine Charrier

http://www.w3.org/2001/XMLSchema#string

P2860

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Retroviral integrations in gene therapy trials

Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency

Efficacy of gene therapy for X-linked severe combined immunodeficiency

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo

P304

257-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTM.2018.03.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29707600

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5918176

http://www.w3.org/2001/XMLSchema#string